|
RALGPS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.60220000050759E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.25370000001202E-07 |
| Normal-vs-Stage2 |
4.67339999998817E-06 |
| Normal-vs-Stage3 |
1.81370000129633E-08 |
| Normal-vs-Stage4 |
3.52540000525536E-08 |
| Stage1-vs-Stage2 |
4.941000E-01 |
| Stage1-vs-Stage3 |
4.277700E-03 |
| Stage1-vs-Stage4 |
2.380200E-04 |
| Stage2-vs-Stage3 |
1.191610E-01 |
| Stage2-vs-Stage4 |
2.234300E-02 |
| Stage3-vs-Stage4 |
4.578200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.46119999830685E-08 |
| Normal-vs-AfricanAmerican |
4.01190000000051E-05 |
| Normal-vs-Asian |
2.02910000000056E-05 |
| Caucasian-vs-AfricanAmerican |
4.003600E-01 |
| Caucasian-vs-Asian |
1.422840E-01 |
| AfricanAmerican-vs-Asian |
6.068200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.04759999997039E-06 |
| Normal-vs-Female |
9.4992999999377E-07 |
| Male-vs-Female |
7.128600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.02239996655629E-09 |
| Normal-vs-Extreme_Weight |
3.10819999960188E-07 |
| Normal-vs-Obese |
4.08299999999917E-05 |
| Normal-vs-Extreme_Obese |
1.041990E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.531800E-01 |
| Normal_Weight-vs-Obese |
1.445630E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.902570E-01 |
| Extreme_Weight-vs-Obese |
5.549400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.528800E-01 |
| Obese-vs-Extreme_Obese |
7.438000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.03279999996708E-06 |
| Normal-vs-Age(41-60Yrs) |
1.56762999999893E-05 |
| Normal-vs-Age(61-80Yrs) |
4.32090000002106E-07 |
| Normal-vs-Age(81-100Yrs) |
3.45030000126201E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.095450E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.468600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.172000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.405750E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.991700E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.281100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.86652999999426E-05 |
| Normal-VS-Type2 PRCC |
3.31623617455534E-13 |
| Normal-VS-KIRP CIMP |
2.60602650570263E-12 |
| Normal-VS-Unclassified PRCC |
2.776200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.01170000044171E-07 |
| Type1 PRCC-VS-KIRP CIMP |
9.84729999764511E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
4.558400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.688100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.718700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.809340E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.49049694598125E-12 |
| Normal-vs-N1 |
1.11950004821892E-09 |
| Normal-vs-N2 |
3.9655999999999E-05 |
| N0-vs-N1 |
2.940600E-01 |
| N0-vs-N2 |
6.085800E-02 |
| N1-vs-N2 |
2.015600E-01 |
|
|
